Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.

Sarah Hochmann; Michaela Mittermeir; Radmila Santic; Frieder Koszik; Lanay Griessner; Alina Sonderegger; Thomas Hoffmann; Elisabeth Russe; Sandra Scheiblhofer; Richard Weiss; Markus Mandler; Achim Schneeberger; Dirk Strunk

doi:10.1038/s41598-018-31061-w

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.

Sarah Hochmann (First author)
, Michaela Mittermeir (Co-author)
, Radmila Santic
, Frieder Koszik
, Lanay Griessner
, Alina Sonderegger (Co-author)
, Thomas Hoffmann
, Elisabeth Russe (Co-author)
, Sandra Scheiblhofer
, Richard Weiss
, Markus Mandler
, Achim Schneeberger
, Dirk Strunk^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

14 Citations (Web of Science)

Original language	English
Pages (from-to)	12954
Journal	Scientific reports
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41598-018-31061-w
Publication status	Published - 2018

Keywords

BASAL-CELL CARCINOMA
INTRALESIONAL INTERFERON-ALPHA-2B
ACTINIC KERATOSES
MAMMALIAN-CELLS
CAP ANALOGS
GENE GUN
STABILITY
DELIVERY
DNA
THERAPEUTICS

Access to Document

10.1038/s41598-018-31061-w

Cite this

Hochmann, S., Mittermeir, M., Santic, R., Koszik, F., Griessner, L., Sonderegger, A., Hoffmann, T., Russe, E., Scheiblhofer, S., Weiss, R., Mandler, M., Schneeberger, A., & Strunk, D. (2018). Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Scientific reports, 8(1), 12954. https://doi.org/10.1038/s41598-018-31061-w

@article{276e6f0ad2094dbb98773cb8b5b7222d,

title = "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.",

keywords = "BASAL-CELL CARCINOMA, INTRALESIONAL INTERFERON-ALPHA-2B, ACTINIC KERATOSES, MAMMALIAN-CELLS, CAP ANALOGS, GENE GUN, STABILITY, DELIVERY, DNA, THERAPEUTICS",

author = "Sarah Hochmann and Michaela Mittermeir and Radmila Santic and Frieder Koszik and Lanay Griessner and Alina Sonderegger and Thomas Hoffmann and Elisabeth Russe and Sandra Scheiblhofer and Richard Weiss and Markus Mandler and Achim Schneeberger and Dirk Strunk",

note = "Hochmann, S: Mittermeir, M; Sonderegger, AS; Strunk, D: Cell Therapy Institute, Paracelsus Medical University, Salzburg, Austria. Spinal Cord Injury and Tissue Regeneration Center Salzburg (Sci-TReCS), Paracelsus Medical University, Salzburg, Austria; Lehr-KH: Russe, E: Department of Plastic, Aesthetic and Reconstructive Surgery, Hospital Barmherzige Brueder, Salzburg, Austria. ",

year = "2018",

doi = "10.1038/s41598-018-31061-w",

language = "English",

volume = "8",

pages = "12954",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Publishing Group ",

number = "1",

}

Hochmann, S, Mittermeir, M, Santic, R, Koszik, F, Griessner, L, Sonderegger, A, Hoffmann, T, Russe, E, Scheiblhofer, S, Weiss, R, Mandler, M, Schneeberger, A & Strunk, D 2018, 'Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.', Scientific reports, vol. 8, no. 1, pp. 12954. https://doi.org/10.1038/s41598-018-31061-w

TY - JOUR

T1 - Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.

AU - Hochmann, Sarah

AU - Mittermeir, Michaela

AU - Santic, Radmila

AU - Koszik, Frieder

AU - Griessner, Lanay

AU - Sonderegger, Alina

AU - Hoffmann, Thomas

AU - Russe, Elisabeth

AU - Scheiblhofer, Sandra

AU - Weiss, Richard

AU - Mandler, Markus

AU - Schneeberger, Achim

AU - Strunk, Dirk

N1 - Hochmann, S: Mittermeir, M; Sonderegger, AS; Strunk, D: Cell Therapy Institute, Paracelsus Medical University, Salzburg, Austria. Spinal Cord Injury and Tissue Regeneration Center Salzburg (Sci-TReCS), Paracelsus Medical University, Salzburg, Austria; Lehr-KH: Russe, E: Department of Plastic, Aesthetic and Reconstructive Surgery, Hospital Barmherzige Brueder, Salzburg, Austria.

PY - 2018

Y1 - 2018

KW - BASAL-CELL CARCINOMA

KW - INTRALESIONAL INTERFERON-ALPHA-2B

KW - ACTINIC KERATOSES

KW - MAMMALIAN-CELLS

KW - CAP ANALOGS

KW - GENE GUN

KW - STABILITY

KW - DELIVERY

KW - DNA

KW - THERAPEUTICS

U2 - 10.1038/s41598-018-31061-w

DO - 10.1038/s41598-018-31061-w

M3 - Original Article

C2 - 30154486

SN - 2045-2322

VL - 8

SP - 12954

JO - Scientific reports

JF - Scientific reports

IS - 1

ER -